derinox 250 mg/5 ml polvo para suspension oral
farmindustria s.a. - polvo para suspension oral
derinox 250mg/5ml 250 mg/5 ml suspension
farmindustria s.a. - suspension
derinox 250mg/5ml polvo para suspension oral
farmindustria s.a. - polvo para suspension oral
derinox 875mg tableta recubierta
farmindustria s.a. - tableta recubierta
derinox 1g tableta para suspension oral
farmindustria s.a. - tableta para suspension oral
derinox comprimidos dispersables 1 g
laboratorios recalcine s.a. - amoxicilina - sin formulas
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - la carmustina - hodgkin disease; lymphoma, non-hodgkin - agentes antineoplásicos - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).